Results 41 to 50 of about 24,328 (140)
In a case series from a hospital in North India, A. nidulans strains isolated from patients with pulmonary aspergillosis were phenotypically identified and then underwent molecular characterization through sequencing of the amplified ITS1‐5.8S rDNA‐ITS2 region and antifungal susceptibility testing (AST) according to the CLSI M38A3 guidelines.
Aishwarya Nikhil +8 more
wiley +1 more source
The Dual Role of Autophagy in Cancer: Mechanisms and Therapeutic Strategies
Autophagy is a conserved cellular process degrading dysfunctional organelles and protein aggregates to maintain cell homeostasis, and it exhibits context‐dependent duality in cancer. Autophagy functions as a critical tumor‐suppressive mechanism by preventing DNA damage and mutation during tumor initiation.
Xiang‐Zheng Gao +4 more
wiley +1 more source
Targeting EZH2 in Cancer: From Molecular Mechanisms to Clinical Translation
The abnormal overexpression or gain‐of‐function mutations of EZH2 play a significant role in cancer occurrence and progression, highlighting the importance and potential of EZH2 as a cancer biomarker. Therefore, screening for effective and safe small‐molecule inhibitors, degraders, and natural compounds targeting EZH2 through preclinical cancer models ...
Xi Zhong +4 more
wiley +1 more source
Pulmonary alveolar proteinosis (PAP) is an ultra‐rare lung disease that can recur even years after bilateral lung transplantation, as in this 73‐year‐old man whose diagnosis was delayed by PAS‐negative BAL and overlapping opportunistic infections (Nocardia, MAC, Aspergillus). Despite initially normal post‐transplant spirometry, he developed progressive
Omar Lopez +3 more
wiley +1 more source
ABSTRACT Anticancer agents with favorable safety profiles, such as immunomodulators and molecular‐targeted agents, are increasingly used in recent cancer therapy, and clinical trials for these agents increasingly incorporate healthy volunteers as well as cancer patients.
Kana Morihisa +3 more
wiley +1 more source
JEADV Clinical Practice, Volume 5, Issue 2, Page 708-709, June 2026.
Sunil Jaiswal +4 more
wiley +1 more source
JEADV Clinical Practice, Volume 5, Issue 2, Page 712-713, June 2026.
Sunil Jaiswal +4 more
wiley +1 more source
ABSTRACT Background Chronic and recalcitrant dermatophytosis has become increasingly problematic in dermatology practice, largely due to emerging antifungal resistance, affecting not only terbinafine but also azoles. Among the causative agents, Trichophyton indotineae has emerged as a key pathogen associated with treatment failure, extensive disease ...
Murat Durdu +8 more
wiley +1 more source
International Journal of Dermatology, Volume 65, Issue 6, Page 1260-1262, June 2026.
Livia Ayuni +7 more
wiley +1 more source
In Vitro Antifungal Drug Susceptibility of Feline Sporothrix schenckii Complex Isolates, Thailand, 2023-2025. [PDF]
Yurayart C +6 more
europepmc +1 more source

